Surgery Partners

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGRY and other ETFs, options, and stocks.

About SGRY

Surgery Partners, Inc. is healthcare services holding company, which engages in the provision of solutions for surgical and related ancillary care in support of its patients and physicians. It operates through the following business segments: Surgical Facility Services, Ancillary Services, and Optical Services. 

CEO
J. Eric Evans
CEOJ. Eric Evans
Employees
15,000
Employees15,000
Headquarters
Brentwood, Tennessee
HeadquartersBrentwood, Tennessee
Founded
2004
Founded2004
Employees
15,000
Employees15,000

SGRY Key Statistics

Market cap
1.98B
Market cap1.98B
Price-Earnings ratio
-11.27
Price-Earnings ratio-11.27
Dividend yield
Dividend yield
Average volume
3.48M
Average volume3.48M
High today
$15.63
High today$15.63
Low today
$15.12
Low today$15.12
Open price
$15.33
Open price$15.33
Volume
3.03M
Volume3.03M
52 Week high
$26.16
52 Week high$26.16
52 Week low
$15.12
52 Week low$15.12

Stock Snapshot

With a market cap of 1.98B, Surgery Partners(SGRY) trades at $15.33. The stock has a price-to-earnings ratio of -11.27.

During the trading session on 2025-11-15, Surgery Partners(SGRY) shares reached a daily high of $15.63 and a low of $15.12. At a current price of $15.33, the stock is +1.4% higher than the low and still -1.9% under the high.

Trading volume for Surgery Partners(SGRY) stock has reached 3.03M, versus its average volume of 3.48M.

The stock's 52-week range extends from a low of $15.12 to a high of $26.16.

The stock's 52-week range extends from a low of $15.12 to a high of $26.16.

SGRY News

TipRanks 2d
Surgery Partners price target lowered to $29 from $34 at UBS

UBS lowered the firm’s price target on Surgery Partners (SGRY) to $29 from $34 and keeps a Buy rating on the shares. Meet Your ETF AI Analyst Discover how Tip...

TipRanks 3d
Surgery Partners Appoints New COO and President

Meet Your ETF AI Analyst Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions AI Analyst can help you make smarter investment...

TipRanks 4d
Strategic Growth and Portfolio Optimization Drive Buy Rating for Surgery Partners

Analyst Ryan Langston of TD Cowen maintained a Buy rating on Surgery Partners, retaining the price target of $28.00. Meet Your ETF AI Analyst Discover how TipRa...

Analyst ratings

82%

of 11 ratings
Buy
81.8%
Hold
18.2%
Sell
0%

More SGRY News

Simply Wall St 4d
Can Surgery Partners' Updated Guidance Change the Conversation on Profitability?

On November 10, 2025, Surgery Partners reported third-quarter results with sales of US$821.5 million and a reduced net loss of US$22.7 million, and issued updat...

Can Surgery Partners' Updated Guidance Change the Conversation on Profitability?
TipRanks 5d
Surgery Partners Reports Q3 2025 Financial Results

Surgery Partners Inc. ( (SGRY) ) has released its Q3 earnings. Here is a breakdown of the information Surgery Partners Inc. presented to its investors. Meet Yo...

TipRanks 5d
Surgery Partners Inc. Earnings Call: Mixed Results and Revised Guidance

Surgery Partners Inc. ((SGRY)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF A...

The Motley Fool 5d
Why Surgery Partners Stock Plummeted on Monday

Investors clearly found much to dislike in the latest earnings report. Surgery Partners (SGRY 25.42%) had a crushingly bad day on the stock market Monday. Inve...

Why Surgery Partners Stock Plummeted on Monday
Nasdaq 5d
Surgery Partners Shares Plunge 24.91% After Q3 Revenue Slightly Misses, Guidance Cut

(RTTNews) - Surgery Partners, Inc. (SGRY) fell 24.91% to $16.15, down $5.35, after reporting third quarter 2025 revenue of $821.5 million, up 6.6 percent year-o...

Surgery Partners Shares Plunge 24.91% After Q3 Revenue Slightly Misses, Guidance Cut
TipRanks 5d
Strategic Divestitures and Financial Leverage: A Buy Rating for Surgery Partners

Analyst Brian Tanquilut of Jefferies maintained a Buy rating on Surgery Partners, with a price target of $28.00. Meet Your ETF AI Analyst Discover how TipRanks'...

People also own

Based on the portfolios of people who own SGRY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.